Citation Impact
Citing Papers
Atherosclerotic Disease of the Aortic Arch as a Risk Factor for Recurrent Ischemic Stroke
1996 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor Trafficking
2008 StandoutNobel
Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
2003
Mechanisms of Thrombus Formation
2008 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Medical Treatment of Peripheral Arterial Disease and Claudication
2001
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Cardiac Disease in Chronic Uremia: Pathophysiology
1997
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis
1997
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic Stroke
1994 Standout
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Nitric Oxide in the Vasculature: Physiology and Pathophysiology
1997
Sepsis-induced myocardial dysfunction: pathophysiology and management
2016
What is the real physiological NO concentration in vivo?
2009
Uric Acid and Cardiovascular Risk
2008 Standout
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
2004 StandoutNature
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
1998 StandoutNobel
Gout
2009 Standout
Differential survival after coronary revascularization procedures among patients with renal insufficiency
2001
Paracrine and autocrine effects of nitric oxide on myocardial function
2000
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
A causal role for uric acid in fructose-induced metabolic syndrome
2005
Platelet Activation and Atherothrombosis
2007 Standout
Poor Long-Term Survival After Coronary Angiography in Patients With Renal Insufficiency
2001
Sepsis and septic shock
2018 Standout
Glial and neuronal control of brain blood flow
2010 StandoutNature
The Vascular Endothelium in Hypertension
2006
The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase
2001
Chronic Kidney Disease, Mortality, and Treatment Strategies among Patients with Clinically Significant Coronary Artery Disease
2003
Association of chronic kidney disease with clinical outcomes after coronary revascularization: The arterial revascularization therapies study (ARTS)
2005
Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study
1996
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
2006 Standout
Hypertrophic Cardiomyopathy
2002 Standout
Lethal Effect of Cytokine-induced Nitric Oxide and Peroxynitrite on Cultured Rat Cardiac Myocytes
2002
Influence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfusion model
2003
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial)
2003
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
The role of infrapopliteal angioplasty
2004
Upregulation of Vascular NAD(P)H Oxidase Subunit gp91phox and Impairment of the Nitric Oxide Signal Transduction Pathway in Hypertension
2001
Management of peripheral arterial disease in primary care
2003
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
Percutaneous Arterial Closure Devices
2003
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions
2002
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Biomarkers in Heart Failure
2008 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Converting Enzyme Inhibition Specifically Prevents the Development and Induces Regression of Cardiac Hypertrophy in Rats
1989
Nitric oxide as a regulator of tissue oxygen consumption
1999
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
2005 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes
2002
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
1991 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study
1998
Molecular mechanisms and therapeutic strategies related to nitric oxide
1995
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans
2002 Standout
Endothelial Dysfunction Coincides With an Enhanced Nitric Oxide Synthase Expression and Superoxide Anion Production
1997
Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension
1998 StandoutNobel
Decreased Coronary Flow Reserve in Hypertrophic Cardiomyopathy Is Related to Remodeling of the Coronary Microcirculation
1998
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Survival After Coronary Revascularization Among Patients With Kidney Disease
2004
Intravascular flow decreases erythrocyte consumption of nitric oxide
1999
Arterial Wall Hypertrophy and Stiffness in Essential Hypertensive Patients
1995
Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation
2002
Cardiac-Specific Overexpression of Inducible Nitric Oxide Synthase Does Not Result in Severe Cardiac Dysfunction
2002
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Chronic Inhibition of Nitric Oxide Synthesis Causes Coronary Microvascular Remodeling in Rats
1995
Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease
2000
Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery
2008
Nitric Oxide and Cardiac Function
2003
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Coronary Plaque Disruption
1995 Standout
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction
2003 Standout
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes
2002
Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart
2002
Are Patients With Renal Failure Good Candidates for Percutaneous Coronary Revascularization in the New Device Era?
2000
Enalapril and Losartan Reduced Cardiac Mass and Improved Coronary Hemodynamics in SHR
1997
Treatment of Periodontitis and Endothelial Function
2007 Standout
Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes
2003
Works of B. E. Strauer being referenced
Regression of Myocardial and Coronary Vascular Hypertrophy in Hypertensive Heart Disease
1988
Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography
1997
Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis
1992
Peripheral Vascular Effects of Beta-Blockers
1994
Transient myocardial ischaemia in hypertensives: missing link with left ventricular hypertrophy
1992
Impaired effectiveness of nitric oxide-donors in resistance arteries of patients with arterial hypertension
1996
Mechanisms of Histamine-Induced Coronary Vasodilatation: H<sub>1</sub>-Receptor-Mediated Release of Endothelium-Derived Nitric Oxide
1993
The Role of Nitric Oxide in the Regulation of Coronary Vascular Resistance in Arterial Hypertension: Comparison of Normotensive and Spontaneously Hypertensive Rats
1992
Reduced peripheral and coronary vasomotion in systemic hypertension
1992
Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation
1997
Periphere arterielle Komplikationen nach Herzkatheteruntersuchung
1998
Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis
1991
Left ventricular function and collagen content after regression of hypertensive hypertrophy.
1989
Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.
1993
Role of Nitric Oxide in the Regulation of Coronary Vascular Tone in Hearts From Hypertensive Rats
1995
Intrakoronare, humane autologe Stammzelltransplantation zur Myokardregeneration nach Herzinfarkt
2001